

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | oligosaccharide catabolic process (GO:0009313) | 4.79035359 |
| 2 | regulation of mononuclear cell migration (GO:0071675) | 4.42990641 |
| 3 | glycosphingolipid catabolic process (GO:0046479) | 4.29674615 |
| 4 | glycolipid catabolic process (GO:0019377) | 4.06071513 |
| 5 | proteasome assembly (GO:0043248) | 4.00329483 |
| 6 | amino sugar catabolic process (GO:0046348) | 3.92254484 |
| 7 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.90273987 |
| 8 | N-acetylneuraminate metabolic process (GO:0006054) | 3.80333727 |
| 9 | keratan sulfate catabolic process (GO:0042340) | 3.79450324 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 3.77338935 |
| 11 | protein maturation by protein folding (GO:0022417) | 3.76231132 |
| 12 | membrane lipid catabolic process (GO:0046466) | 3.59367193 |
| 13 | phagosome maturation (GO:0090382) | 3.55668973 |
| 14 | sphingolipid catabolic process (GO:0030149) | 3.54646061 |
| 15 | immunoglobulin mediated immune response (GO:0016064) | 3.53980770 |
| 16 | ceramide catabolic process (GO:0046514) | 3.53913143 |
| 17 | platelet dense granule organization (GO:0060155) | 3.48533659 |
| 18 | positive regulation of mast cell degranulation (GO:0043306) | 3.44199659 |
| 19 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.44199659 |
| 20 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.44055312 |
| 21 | vitamin D metabolic process (GO:0042359) | 3.38399657 |
| 22 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.36606347 |
| 23 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.36606347 |
| 24 | negative regulation of interleukin-12 production (GO:0032695) | 3.34427886 |
| 25 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.33303932 |
| 26 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.32849147 |
| 27 | response to hydroperoxide (GO:0033194) | 3.28144369 |
| 28 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.27471103 |
| 29 | energy homeostasis (GO:0097009) | 3.27154872 |
| 30 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.26702932 |
| 31 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.25723872 |
| 32 | lactate metabolic process (GO:0006089) | 3.23492076 |
| 33 | respiratory chain complex IV assembly (GO:0008535) | 3.22728312 |
| 34 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.17304293 |
| 35 | xenobiotic catabolic process (GO:0042178) | 3.16085506 |
| 36 | positive regulation of leukocyte degranulation (GO:0043302) | 3.14870389 |
| 37 | C-terminal protein lipidation (GO:0006501) | 3.10542906 |
| 38 | transferrin transport (GO:0033572) | 3.09408328 |
| 39 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.04981850 |
| 40 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.04345997 |
| 41 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.02976346 |
| 42 | response to acidic pH (GO:0010447) | 3.02167809 |
| 43 | mature B cell differentiation involved in immune response (GO:0002313) | 3.00268141 |
| 44 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.96859751 |
| 45 | cytochrome complex assembly (GO:0017004) | 2.96641156 |
| 46 | cellular response to zinc ion (GO:0071294) | 2.92961584 |
| 47 | lysosome organization (GO:0007040) | 2.88895074 |
| 48 | lytic vacuole organization (GO:0080171) | 2.88895074 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.88549224 |
| 50 | negative regulation of cation channel activity (GO:2001258) | 2.86693108 |
| 51 | B cell mediated immunity (GO:0019724) | 2.86095861 |
| 52 | positive regulation of actin filament depolymerization (GO:0030836) | 2.85257811 |
| 53 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.84902596 |
| 54 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.84711291 |
| 55 | ferric iron transport (GO:0015682) | 2.84195746 |
| 56 | trivalent inorganic cation transport (GO:0072512) | 2.84195746 |
| 57 | positive regulation of mast cell activation (GO:0033005) | 2.80592836 |
| 58 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.79447256 |
| 59 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.77409294 |
| 60 | C-terminal protein amino acid modification (GO:0018410) | 2.77188851 |
| 61 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.72827028 |
| 62 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.70777654 |
| 63 | response to thyroid hormone (GO:0097066) | 2.70607687 |
| 64 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.69204067 |
| 65 | intracellular pH reduction (GO:0051452) | 2.67247111 |
| 66 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.66091448 |
| 67 | pH reduction (GO:0045851) | 2.65620288 |
| 68 | regulation of chemokine biosynthetic process (GO:0045073) | 2.64505436 |
| 69 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.64441549 |
| 70 | vitamin biosynthetic process (GO:0009110) | 2.63409540 |
| 71 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.62154844 |
| 72 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.59677766 |
| 73 | glycerophospholipid catabolic process (GO:0046475) | 2.55170637 |
| 74 | glucosamine-containing compound catabolic process (GO:1901072) | 2.54683228 |
| 75 | negative regulation of mast cell activation (GO:0033004) | 2.54544798 |
| 76 | cellular response to arsenic-containing substance (GO:0071243) | 2.54150143 |
| 77 | endosome to melanosome transport (GO:0035646) | 2.54042119 |
| 78 | endosome to pigment granule transport (GO:0043485) | 2.54042119 |
| 79 | purine nucleotide salvage (GO:0032261) | 2.52683611 |
| 80 | cellular response to interferon-gamma (GO:0071346) | 2.50067483 |
| 81 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.49409786 |
| 82 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.48765088 |
| 83 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.48313678 |
| 84 | response to interferon-gamma (GO:0034341) | 2.46931952 |
| 85 | histamine secretion (GO:0001821) | 2.46220189 |
| 86 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.45587708 |
| 87 | positive regulation of calcium ion import (GO:0090280) | 2.45281940 |
| 88 | virion attachment to host cell (GO:0019062) | 2.44051851 |
| 89 | adhesion of symbiont to host cell (GO:0044650) | 2.44051851 |
| 90 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.43772699 |
| 91 | regulation of podosome assembly (GO:0071801) | 2.42706122 |
| 92 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.42307798 |
| 93 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.41833902 |
| 94 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.41228385 |
| 95 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.40616376 |
| 96 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.40519331 |
| 97 | mature B cell differentiation (GO:0002335) | 2.38817883 |
| 98 | T-helper 1 type immune response (GO:0042088) | 2.38177431 |
| 99 | vasodilation (GO:0042311) | 2.37835488 |
| 100 | positive regulation of interleukin-6 production (GO:0032755) | 2.37129859 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.94657311 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.64212995 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.09920965 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.90193512 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.21805549 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.14561019 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.92806266 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.77804983 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.70996569 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.49185092 |
| 11 | TFEB_21752829_ChIP-Seq_HELA_Human | 2.46644216 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.43638163 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.43433721 |
| 14 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.41208948 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.29890396 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.28415964 |
| 17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.17296013 |
| 18 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.06538539 |
| 19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.06234190 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05752200 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02095719 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.01805229 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.98038446 |
| 24 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.91887989 |
| 25 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.91228344 |
| 26 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.90338523 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.89281388 |
| 28 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.86755751 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81387826 |
| 30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.66816489 |
| 31 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.63615605 |
| 32 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.63386117 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.61195681 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.56329299 |
| 35 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.56287589 |
| 36 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.52201198 |
| 37 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.52018270 |
| 38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.50939453 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.50688226 |
| 40 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48200963 |
| 41 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.44310800 |
| 42 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43348406 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.39488727 |
| 44 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.38324754 |
| 45 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.37699397 |
| 46 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.36257575 |
| 47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.35268048 |
| 48 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.26642724 |
| 49 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.21943414 |
| 50 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.21253281 |
| 51 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.21253281 |
| 52 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.17138522 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16780188 |
| 54 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.15978957 |
| 55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.15804512 |
| 56 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.15423339 |
| 57 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.14308783 |
| 58 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.13862899 |
| 59 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11399107 |
| 60 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11319882 |
| 61 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11100702 |
| 62 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.11053309 |
| 63 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08050604 |
| 64 | AR_20517297_ChIP-Seq_VCAP_Human | 1.07354715 |
| 65 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.06710929 |
| 66 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.02836940 |
| 67 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.01830511 |
| 68 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.01453954 |
| 69 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98524601 |
| 70 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98023897 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97656912 |
| 72 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.97517327 |
| 73 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97382531 |
| 74 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.95964847 |
| 75 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95390101 |
| 76 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.94678835 |
| 77 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.94330293 |
| 78 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.93128731 |
| 79 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.93108091 |
| 80 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92535348 |
| 81 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.91515357 |
| 82 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.91422197 |
| 83 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.90968206 |
| 84 | VDR_22108803_ChIP-Seq_LS180_Human | 0.90309111 |
| 85 | CBP_21632823_ChIP-Seq_H3396_Human | 0.89387673 |
| 86 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88180105 |
| 87 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.88125789 |
| 88 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.88079246 |
| 89 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87499250 |
| 90 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87160908 |
| 91 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.86804191 |
| 92 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.86742355 |
| 93 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.86742355 |
| 94 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.84518609 |
| 95 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.83849229 |
| 96 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82925461 |
| 97 | P300_19829295_ChIP-Seq_ESCs_Human | 0.81319417 |
| 98 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.79256028 |
| 99 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78759062 |
| 100 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.78023652 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 5.50814275 |
| 2 | MP0006082_CNS_inflammation | 3.86490966 |
| 3 | MP0009840_abnormal_foam_cell | 3.51367159 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 3.42818191 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.20900286 |
| 6 | MP0006054_spinal_hemorrhage | 2.94547088 |
| 7 | MP0003195_calcinosis | 2.82502098 |
| 8 | MP0003075_altered_response_to | 2.72184824 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.71950825 |
| 10 | MP0000343_altered_response_to | 2.62678399 |
| 11 | MP0009785_altered_susceptibility_to | 2.56489981 |
| 12 | MP0003303_peritoneal_inflammation | 2.52746968 |
| 13 | MP0003724_increased_susceptibility_to | 2.44738251 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.40526115 |
| 15 | MP0009764_decreased_sensitivity_to | 2.36243298 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.26864909 |
| 17 | MP0005167_abnormal_blood-brain_barrier | 2.17606095 |
| 18 | MP0004510_myositis | 2.16329999 |
| 19 | MP0002090_abnormal_vision | 2.13351968 |
| 20 | MP0002254_reproductive_system_inflammat | 2.12167772 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 2.01311305 |
| 22 | MP0005379_endocrine/exocrine_gland_phen | 1.91597138 |
| 23 | MP0001853_heart_inflammation | 1.90724707 |
| 24 | MP0002419_abnormal_innate_immunity | 1.83465882 |
| 25 | MP0010234_abnormal_vibrissa_follicle | 1.77230640 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.71592265 |
| 27 | MP0005365_abnormal_bile_salt | 1.70871277 |
| 28 | MP0000685_abnormal_immune_system | 1.68501493 |
| 29 | MP0003436_decreased_susceptibility_to | 1.65314420 |
| 30 | MP0005671_abnormal_response_to | 1.61146087 |
| 31 | MP0008469_abnormal_protein_level | 1.60768319 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.60301429 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.58082472 |
| 34 | MP0000604_amyloidosis | 1.52742453 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.51097827 |
| 36 | MP0006072_abnormal_retinal_apoptosis | 1.49645004 |
| 37 | MP0006036_abnormal_mitochondrial_physio | 1.46872302 |
| 38 | MP0001790_abnormal_immune_system | 1.45443982 |
| 39 | MP0005387_immune_system_phenotype | 1.45443982 |
| 40 | MP0003186_abnormal_redox_activity | 1.44754733 |
| 41 | MP0005165_increased_susceptibility_to | 1.43962869 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.41166991 |
| 43 | MP0005166_decreased_susceptibility_to | 1.40207971 |
| 44 | MP0002693_abnormal_pancreas_physiology | 1.38657071 |
| 45 | MP0000516_abnormal_urinary_system | 1.37034416 |
| 46 | MP0005367_renal/urinary_system_phenotyp | 1.37034416 |
| 47 | MP0004019_abnormal_vitamin_homeostasis | 1.34045529 |
| 48 | MP0005025_abnormal_response_to | 1.30932180 |
| 49 | MP0001764_abnormal_homeostasis | 1.30322712 |
| 50 | MP0002332_abnormal_exercise_endurance | 1.26478385 |
| 51 | MP0008875_abnormal_xenobiotic_pharmacok | 1.25889025 |
| 52 | MP0002723_abnormal_immune_serum | 1.23513478 |
| 53 | MP0005084_abnormal_gallbladder_morpholo | 1.22395958 |
| 54 | MP0010386_abnormal_urinary_bladder | 1.22148146 |
| 55 | MP0001542_abnormal_bone_strength | 1.22044136 |
| 56 | MP0001756_abnormal_urination | 1.20455194 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 1.18297656 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.18297656 |
| 59 | MP0005332_abnormal_amino_acid | 1.12922394 |
| 60 | MP0003011_delayed_dark_adaptation | 1.12346050 |
| 61 | MP0002909_abnormal_adrenal_gland | 1.06686879 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.03046523 |
| 63 | MP0002163_abnormal_gland_morphology | 1.01352302 |
| 64 | MP0005310_abnormal_salivary_gland | 1.01293475 |
| 65 | MP0005451_abnormal_body_composition | 0.98823618 |
| 66 | MP0003690_abnormal_glial_cell | 0.97972369 |
| 67 | MP0001800_abnormal_humoral_immune | 0.97310445 |
| 68 | MP0009046_muscle_twitch | 0.95656088 |
| 69 | MP0000920_abnormal_myelination | 0.95169158 |
| 70 | MP0000858_altered_metastatic_potential | 0.92823091 |
| 71 | MP0001819_abnormal_immune_cell | 0.91336971 |
| 72 | MP0005464_abnormal_platelet_physiology | 0.90815489 |
| 73 | MP0002420_abnormal_adaptive_immunity | 0.89929686 |
| 74 | MP0005253_abnormal_eye_physiology | 0.88018739 |
| 75 | MP0002277_abnormal_respiratory_mucosa | 0.87625080 |
| 76 | MP0003300_gastrointestinal_ulcer | 0.86984660 |
| 77 | MP0004147_increased_porphyrin_level | 0.84204214 |
| 78 | MP0009333_abnormal_splenocyte_physiolog | 0.82331757 |
| 79 | MP0006035_abnormal_mitochondrial_morpho | 0.81567842 |
| 80 | MP0001243_abnormal_dermal_layer | 0.78934800 |
| 81 | MP0003448_altered_tumor_morphology | 0.78695328 |
| 82 | MP0005257_abnormal_intraocular_pressure | 0.78005568 |
| 83 | MP0010329_abnormal_lipoprotein_level | 0.76911257 |
| 84 | MP0003633_abnormal_nervous_system | 0.76673950 |
| 85 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76390826 |
| 86 | MP0000647_abnormal_sebaceous_gland | 0.74383975 |
| 87 | MP0009763_increased_sensitivity_to | 0.72408067 |
| 88 | MP0005636_abnormal_mineral_homeostasis | 0.72260923 |
| 89 | MP0010155_abnormal_intestine_physiology | 0.70422208 |
| 90 | MP0005535_abnormal_body_temperature | 0.69850871 |
| 91 | MP0001727_abnormal_embryo_implantation | 0.68912475 |
| 92 | MP0003795_abnormal_bone_structure | 0.67865350 |
| 93 | MP0001905_abnormal_dopamine_level | 0.67853723 |
| 94 | MP0003453_abnormal_keratinocyte_physiol | 0.67751324 |
| 95 | MP0009643_abnormal_urine_homeostasis | 0.64981534 |
| 96 | MP0000747_muscle_weakness | 0.64971946 |
| 97 | MP0000358_abnormal_cell_content/ | 0.63341814 |
| 98 | MP0002295_abnormal_pulmonary_circulatio | 0.62085044 |
| 99 | MP0008260_abnormal_autophagy | 0.61933436 |
| 100 | MP0002118_abnormal_lipid_homeostasis | 0.61241111 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 8.34906673 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 8.34906673 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 8.34906673 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 6.63515761 |
| 5 | Dysostosis multiplex (HP:0000943) | 4.06087438 |
| 6 | Loss of speech (HP:0002371) | 4.04729304 |
| 7 | Nuclear cataract (HP:0100018) | 3.90519177 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 3.88053577 |
| 9 | Progressive neurologic deterioration (HP:0002344) | 3.56216674 |
| 10 | Abnormality of macrophages (HP:0004311) | 3.48031462 |
| 11 | Mutism (HP:0002300) | 3.47262628 |
| 12 | Disinhibition (HP:0000734) | 3.31607420 |
| 13 | Hypoglycemic seizures (HP:0002173) | 3.29926816 |
| 14 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.17367880 |
| 15 | Prolonged neonatal jaundice (HP:0006579) | 3.16903228 |
| 16 | Hypoglycemic coma (HP:0001325) | 3.15186610 |
| 17 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.13869310 |
| 18 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.13869310 |
| 19 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.13869310 |
| 20 | Mucopolysacchariduria (HP:0008155) | 3.01173199 |
| 21 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.01173199 |
| 22 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.98188958 |
| 23 | Systemic lupus erythematosus (HP:0002725) | 2.96853927 |
| 24 | Symptomatic seizures (HP:0011145) | 2.90532840 |
| 25 | Hepatic necrosis (HP:0002605) | 2.84532580 |
| 26 | Ketoacidosis (HP:0001993) | 2.79301622 |
| 27 | Hepatocellular necrosis (HP:0001404) | 2.73652708 |
| 28 | Hyperglycemia (HP:0003074) | 2.70096714 |
| 29 | Acute necrotizing encephalopathy (HP:0006965) | 2.61890827 |
| 30 | Hypothermia (HP:0002045) | 2.61629228 |
| 31 | Mitochondrial inheritance (HP:0001427) | 2.60785989 |
| 32 | Increased CSF lactate (HP:0002490) | 2.52933562 |
| 33 | Large for gestational age (HP:0001520) | 2.50372213 |
| 34 | Progressive macrocephaly (HP:0004481) | 2.46259409 |
| 35 | Hypokinesia (HP:0002375) | 2.45115503 |
| 36 | Recurrent abscess formation (HP:0002722) | 2.43890542 |
| 37 | Hematochezia (HP:0002573) | 2.40674978 |
| 38 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.39863946 |
| 39 | Retinal atrophy (HP:0001105) | 2.39598033 |
| 40 | Tongue fasciculations (HP:0001308) | 2.37732723 |
| 41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.37421683 |
| 42 | Generalized aminoaciduria (HP:0002909) | 2.35327154 |
| 43 | Lipid accumulation in hepatocytes (HP:0006561) | 2.33636081 |
| 44 | Axonal loss (HP:0003447) | 2.31125901 |
| 45 | Recurrent bacterial skin infections (HP:0005406) | 2.30113583 |
| 46 | Neurofibrillary tangles (HP:0002185) | 2.28936913 |
| 47 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.27494603 |
| 48 | Respiratory failure (HP:0002878) | 2.25938624 |
| 49 | Cardiomegaly (HP:0001640) | 2.24262106 |
| 50 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.23665713 |
| 51 | Acute encephalopathy (HP:0006846) | 2.23277210 |
| 52 | Zonular cataract (HP:0010920) | 2.22972520 |
| 53 | Abnormality of the basal ganglia (HP:0002134) | 2.20246678 |
| 54 | Diminished motivation (HP:0000745) | 2.19381741 |
| 55 | Increased hepatocellular lipid droplets (HP:0006565) | 2.17814588 |
| 56 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.16633736 |
| 57 | Renal Fanconi syndrome (HP:0001994) | 2.15931335 |
| 58 | Myocardial infarction (HP:0001658) | 2.15024518 |
| 59 | Increased CSF protein (HP:0002922) | 2.14838087 |
| 60 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.14737278 |
| 61 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.14737278 |
| 62 | Apathy (HP:0000741) | 2.12316732 |
| 63 | CNS demyelination (HP:0007305) | 2.10942886 |
| 64 | Metaphyseal irregularity (HP:0003025) | 2.08695662 |
| 65 | Late onset (HP:0003584) | 2.07903020 |
| 66 | Stomatitis (HP:0010280) | 2.07718511 |
| 67 | Xanthomatosis (HP:0000991) | 2.07716869 |
| 68 | Global brain atrophy (HP:0002283) | 2.07648143 |
| 69 | Hepatosplenomegaly (HP:0001433) | 2.06102545 |
| 70 | Nausea (HP:0002018) | 2.04894231 |
| 71 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.04296224 |
| 72 | Exertional dyspnea (HP:0002875) | 2.00620173 |
| 73 | Poor head control (HP:0002421) | 1.99842842 |
| 74 | Petechiae (HP:0000967) | 1.95847683 |
| 75 | Prominent metopic ridge (HP:0005487) | 1.94173681 |
| 76 | Amyloidosis (HP:0011034) | 1.93603091 |
| 77 | Autoimmune thrombocytopenia (HP:0001973) | 1.92883299 |
| 78 | Type I transferrin isoform profile (HP:0003642) | 1.90060636 |
| 79 | Degeneration of anterior horn cells (HP:0002398) | 1.89623473 |
| 80 | Abnormality of the anterior horn cell (HP:0006802) | 1.89623473 |
| 81 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.89018900 |
| 82 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.89018900 |
| 83 | Sensorimotor neuropathy (HP:0007141) | 1.88953443 |
| 84 | Muscle fibrillation (HP:0010546) | 1.88290456 |
| 85 | Polyneuropathy (HP:0001271) | 1.87185385 |
| 86 | Agitation (HP:0000713) | 1.86038485 |
| 87 | Azoospermia (HP:0000027) | 1.84212360 |
| 88 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.83397596 |
| 89 | Basal ganglia calcification (HP:0002135) | 1.83340626 |
| 90 | Glomerulonephritis (HP:0000099) | 1.82389702 |
| 91 | Polyphagia (HP:0002591) | 1.82227985 |
| 92 | Increased serum pyruvate (HP:0003542) | 1.81976748 |
| 93 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.80456965 |
| 94 | Ketosis (HP:0001946) | 1.76718364 |
| 95 | Increased serum ferritin (HP:0003281) | 1.76490922 |
| 96 | Lactic acidosis (HP:0003128) | 1.76254836 |
| 97 | Cerebral edema (HP:0002181) | 1.75930622 |
| 98 | Multiple enchondromatosis (HP:0005701) | 1.75804756 |
| 99 | 3-Methylglutaconic aciduria (HP:0003535) | 1.75344576 |
| 100 | Beaking of vertebral bodies (HP:0004568) | 1.74358769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 3.35743092 |
| 2 | MAP3K12 | 3.07756557 |
| 3 | TESK1 | 3.04866231 |
| 4 | NME2 | 3.01159851 |
| 5 | LIMK1 | 2.62083246 |
| 6 | MST4 | 2.60623063 |
| 7 | BMPR2 | 2.50601423 |
| 8 | BCKDK | 2.39647443 |
| 9 | IRAK3 | 2.38732792 |
| 10 | FRK | 2.30301979 |
| 11 | TRIM28 | 2.04706924 |
| 12 | GRK7 | 1.91473790 |
| 13 | CSNK1G3 | 1.90919450 |
| 14 | BLK | 1.89382990 |
| 15 | PIM2 | 1.81649150 |
| 16 | ADRBK2 | 1.77686339 |
| 17 | TGFBR2 | 1.76704416 |
| 18 | DAPK1 | 1.75623703 |
| 19 | ACVR1B | 1.68564330 |
| 20 | CSNK1A1L | 1.60349963 |
| 21 | CSNK1G1 | 1.60036685 |
| 22 | TESK2 | 1.56438017 |
| 23 | CSNK1G2 | 1.54547368 |
| 24 | GRK1 | 1.53448718 |
| 25 | CDK19 | 1.50601298 |
| 26 | CAMKK2 | 1.47148132 |
| 27 | ERBB3 | 1.44447699 |
| 28 | DAPK2 | 1.41309855 |
| 29 | PAK4 | 1.40754611 |
| 30 | NUAK1 | 1.39097325 |
| 31 | ZAK | 1.35546324 |
| 32 | TBK1 | 1.35166622 |
| 33 | ARAF | 1.33015291 |
| 34 | WNK3 | 1.32316255 |
| 35 | STK16 | 1.28833498 |
| 36 | MYLK | 1.28817095 |
| 37 | ABL2 | 1.27451692 |
| 38 | MAP4K2 | 1.24683939 |
| 39 | BUB1 | 1.14729961 |
| 40 | FER | 1.13499682 |
| 41 | PHKG1 | 1.12547698 |
| 42 | PHKG2 | 1.12547698 |
| 43 | MAPKAPK3 | 1.10143600 |
| 44 | IKBKB | 1.08429551 |
| 45 | DDR2 | 1.05714581 |
| 46 | MATK | 1.04520420 |
| 47 | TNIK | 1.04214411 |
| 48 | TYK2 | 1.03277534 |
| 49 | PLK2 | 0.99806721 |
| 50 | MAP2K7 | 0.98981011 |
| 51 | TLK1 | 0.98838644 |
| 52 | OXSR1 | 0.97814521 |
| 53 | MOS | 0.94082197 |
| 54 | SCYL2 | 0.93493143 |
| 55 | CSF1R | 0.90817678 |
| 56 | PLK3 | 0.89100096 |
| 57 | IRAK4 | 0.87594695 |
| 58 | CCNB1 | 0.87138266 |
| 59 | VRK2 | 0.86479556 |
| 60 | MAP2K6 | 0.85814775 |
| 61 | MAP3K14 | 0.84112012 |
| 62 | TAOK2 | 0.82955827 |
| 63 | BMPR1B | 0.81414941 |
| 64 | FGR | 0.79094871 |
| 65 | TRPM7 | 0.77750525 |
| 66 | DAPK3 | 0.75943806 |
| 67 | EIF2AK3 | 0.73975599 |
| 68 | MAP3K11 | 0.72781953 |
| 69 | JAK3 | 0.71773876 |
| 70 | BCR | 0.68912391 |
| 71 | ERBB4 | 0.65057346 |
| 72 | STK10 | 0.62766064 |
| 73 | SIK3 | 0.61483711 |
| 74 | TGFBR1 | 0.59617241 |
| 75 | MAP3K5 | 0.59519397 |
| 76 | MAP3K4 | 0.58377714 |
| 77 | TEC | 0.57889475 |
| 78 | INSRR | 0.55581590 |
| 79 | PRKCE | 0.54770051 |
| 80 | ABL1 | 0.52512189 |
| 81 | CHUK | 0.51887912 |
| 82 | PLK4 | 0.49374451 |
| 83 | NEK1 | 0.49350114 |
| 84 | LYN | 0.49022156 |
| 85 | KDR | 0.48432209 |
| 86 | IRAK1 | 0.48304482 |
| 87 | MAPKAPK5 | 0.48007577 |
| 88 | TAOK3 | 0.47817957 |
| 89 | CAMK2D | 0.47076713 |
| 90 | VRK1 | 0.44689089 |
| 91 | PAK1 | 0.42626800 |
| 92 | LMTK2 | 0.38674120 |
| 93 | ILK | 0.38195094 |
| 94 | ERN1 | 0.37511427 |
| 95 | CSNK1A1 | 0.37420948 |
| 96 | IRAK2 | 0.36867622 |
| 97 | EIF2AK1 | 0.36042568 |
| 98 | EPHA2 | 0.35033760 |
| 99 | CAMK2G | 0.34913193 |
| 100 | RPS6KA4 | 0.34791324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 3.90402696 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.68467815 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 3.07312191 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.01681473 |
| 5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.99186397 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.85840238 |
| 7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.77845712 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.68032875 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.49139647 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.44854926 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.43610979 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.42852931 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.36959915 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.36513858 |
| 15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.24069816 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.13522540 |
| 17 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.06280522 |
| 18 | Protein export_Homo sapiens_hsa03060 | 1.94755128 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.83931631 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.74826378 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.65863456 |
| 22 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.63891378 |
| 23 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.59466938 |
| 24 | Phagosome_Homo sapiens_hsa04145 | 1.57348796 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.55197805 |
| 26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.46231382 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.40222748 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.33696211 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32556474 |
| 30 | Parkinsons disease_Homo sapiens_hsa05012 | 1.31811879 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27509143 |
| 32 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.26841030 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.16152615 |
| 34 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.15304438 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.10610947 |
| 36 | Mineral absorption_Homo sapiens_hsa04978 | 1.06807156 |
| 37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.05513866 |
| 38 | Galactose metabolism_Homo sapiens_hsa00052 | 1.05252386 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.02095100 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.00789666 |
| 41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.99546173 |
| 42 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.97880916 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97285464 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 0.96892750 |
| 45 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.95674590 |
| 46 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.95155706 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95089889 |
| 48 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.94621147 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.90750463 |
| 50 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.87805095 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84206478 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.83021166 |
| 53 | Peroxisome_Homo sapiens_hsa04146 | 0.81748551 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.80170333 |
| 55 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.79285505 |
| 56 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.78711152 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70913098 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69676450 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69499706 |
| 60 | Huntingtons disease_Homo sapiens_hsa05016 | 0.69320896 |
| 61 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.66228606 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 0.64387804 |
| 63 | Malaria_Homo sapiens_hsa05144 | 0.62681767 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.61505068 |
| 65 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.60884157 |
| 66 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58365797 |
| 67 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.56116667 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.54723385 |
| 69 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54402486 |
| 70 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.54009276 |
| 71 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51374195 |
| 72 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.48727899 |
| 73 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48674027 |
| 74 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.43853799 |
| 75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.42160779 |
| 76 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.41601798 |
| 77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38013686 |
| 78 | Homologous recombination_Homo sapiens_hsa03440 | 0.37370606 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37144287 |
| 80 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36651910 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36524548 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35844536 |
| 83 | RNA polymerase_Homo sapiens_hsa03020 | 0.34159487 |
| 84 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.34044353 |
| 85 | Carbon metabolism_Homo sapiens_hsa01200 | 0.33882760 |
| 86 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.33538682 |
| 87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.31985687 |
| 88 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31514324 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.31254537 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.31145698 |
| 91 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.30632199 |
| 92 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28943411 |
| 93 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.28815708 |
| 94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.26818764 |
| 95 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.26193197 |
| 96 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.24773708 |
| 97 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.24454555 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.23691699 |
| 99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22801992 |
| 100 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.20721040 |

